Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...

Edwards Lifesciences (NYSE:EW) announced today that it received CE mark approval for its Sapien M3 mitral valve replacement ...

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.